Oxford Index Search Results

You are looking at 1-10 of 281 items for:

punt x clear all
Did you mean:

Refine by subject

 

Refine by type

Refine by product

 

punt

Overview page. Subjects: Financial Institutions and Services.

(Ir£) The Irish pound: formerly the standard monetary unit of the Republic of Ireland, divided into 100 pence. It was subsumed into the euro for all purposes except cash transactions in...

See overview in Oxford Index

O-018Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC)

T. Ruers, C.J.A. Punt, F. van Coevorden, J.-P. Pierie, I. Borel Rinkes, J. Ledermann, G. Poston, W. Bechstein, M.-A. Lentz, M. Mauer, E. Van Cutsem, M. Lutz and B. Nordlinger.

in Annals of Oncology

June 2015; p ublished online June 2015 .

Journal Article. Subjects: Medical Oncology. 388 words.

Go to Oxford Journals »  abstract

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial<sup> </sup>

A. J. Breugom, W. van Gijn, E. W. Muller, Å. Berglund, C. B. M. van den Broek, T. Fokstuen, H. Gelderblom, E. Kapiteijn, J. W. H. Leer, C. A. M. Marijnen, H. Martijn, E. Meershoek-Klein Kranenbarg, I. D. Nagtegaal, L. Påhlman, C. J. A. Punt, H. Putter, A. G. H. Roodvoets, H. J. T. Rutten, W. H. Steup, B. Glimelius and C. J. H. van de Velde.

in Annals of Oncology

April 2015; p ublished online December 2014 .

Journal Article. Subjects: Medical Oncology. 3476 words.

Background

The discussion on the role of adjuvant chemotherapy for rectal cancer patients treated according to current guidelines is still ongoing. A...

Go to Oxford Journals »  home page

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

T. Ruers, C. Punt, F. Van Coevorden, J. P. E. N. Pierie, I. Borel-Rinkes, J. A. Ledermann, G. Poston, W. Bechstein, M. A. Lentz, M. Mauer, E. Van Cutsem, M. P. Lutz and B. Nordlinger.

in Annals of Oncology

October 2012; p ublished online March 2012 .

Journal Article. Subjects: Medical Oncology. 4504 words.

Background

This study investigates the possible benefits of radiofrequency ablation (RFA) in patients with non-resectable colorectal liver metastases.

null...

Go to Oxford Journals »  abstract

Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer

M. Peeters, T. J. Price, A. Cervantes, A. F. Sobrero, M. Ducreux, Y. Hotko, T. André, E. Chan, F. Lordick, C. J. A. Punt, A. H. Strickland, G. Wilson, T. E. Ciuleanu, L. Roman, E. Van Cutsem, Y. Tian and R. Sidhu.

in Annals of Oncology

January 2014; p ublished online January 2014 .

Journal Article. Subjects: Medical Oncology. 4547 words.

Background

The study 20050181 demonstrated significant improvements in progression-free survival (PFS), objective response, and a nonsignificant trend toward...

Go to Oxford Journals »  abstract

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents

J. Tol, M. Koopman, M. C. Miller, A. Tibbe, A. Cats, G. J. M. Creemers, A. H. Vos, I. D. Nagtegaal, L. W. M. M. Terstappen and C. J. A. Punt.

in Annals of Oncology

May 2010; p ublished online October 2009 .

Journal Article. Subjects: Medical Oncology. 4361 words.

Background: Early predictive markers for response are needed for advanced colorectal cancer (ACC) patients. We assessed the value of circulating tumour cells (CTC) in ACC...

Go to Oxford Journals »  abstract

Management of isolated nonresectable liver metastases in colorectal cancer patients: a case–control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy

L. B. J. van Iersel, M. Koopman, C. J. H. van de Velde, L. Mol, E. L. van Persijn van Meerten, H. H. Hartgrink, P. J. K. Kuppen, A. L. Vahrmeijer, J. W. R Nortier, R. A. E. M. Tollenaar, C. Punt and H. Gelderblom.

in Annals of Oncology

August 2010; p ublished online January 2010 .

Journal Article. Subjects: Medical Oncology. 3635 words.

Background: To compare the median overall survival of patients with isolated nonresectable liver metastases in comparable groups of patients treated with either isolated...

Go to Oxford Journals »  abstract

Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer

L.F. de Geus-Oei, H. W. M. van Laarhoven, E. P. Visser, R. Hermsen, B. A. van Hoorn, Y. J. L. Kamm, P. F. M. Krabbe, F. H. M. Corstens, C. J. A. Punt and W. J. G. Oyen.

in Annals of Oncology

February 2008; p ublished online October 2007 .

Journal Article. Subjects: Medical Oncology. 3471 words.

Background: The aim of this prospective study was to evaluate the value of F-18-fluorodeoxyglucose–positron emission tomography (FDG–PET) for early assessment of chemotherapy...

Go to Oxford Journals »  abstract

DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer

C. Postma, M. Koopman, T. E. Buffart, P. P. Eijk, B. Carvalho, G. J. Peters, B. Ylstra, J. H. van Krieken, C. J. A. Punt and G. A. Meijer.

in Annals of Oncology

June 2009; p ublished online January 2009 .

Journal Article. Subjects: Medical Oncology. 4473 words.

Background: Colorectal cancer (CRC) is biologically a heterogeneous disease, which may affect response to drug therapy. We investigated the correlation of genome-wide DNA copy...

Go to Oxford Journals »  abstract

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

S. J. Cohen, C. J. A. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. A. Morse, E. Mitchell, M. C. Miller, G. V. Doyle, H. Tissing, L. W. M. M. Terstappen and N. J. Meropol.

in Annals of Oncology

July 2009; p ublished online March 2009 .

Journal Article. Subjects: Medical Oncology. 2644 words.

Background: We demonstrated that circulating tumor cell (CTC) number at baseline and follow-up is an independent prognostic factor in metastatic colorectal cancer (mCRC). This...

Go to Oxford Journals »  abstract

Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study

C. J. A. Punt, H. J. Keizer, J. Douma, T. Skovsgaard, J. Schüller, E. W. Muller, C. H. H. Ten Napel, J. J. Croles, H. Lochs, J. Zhang and L. Hammershaimb.

in Annals of Oncology

January 2002; p ublished online January 2002 .

Journal Article. Subjects: Medical Oncology. 3470 words.

Background

Trimetrexate (TMTX) is a biochemical modulator of 5-fluorouracil (5-FU) and leucovorin (LV). Phase II trials have shown promising activity of...

Go to Oxford Journals »  abstract